Arlart I P, Wagner H, Rosenthal J
Klin Wochenschr. 1978 Jun 15;56(12):625-7. doi: 10.1007/BF01477012.
A central stimulatory effect of angiotensin II (AII) on the secretion of arginine-vasopressin (AVP) has been described. The competitive blocker of AII, saralasin (SAR) has been used for diagnostic purposes in angiotensin-dependent hypertension. In addition SAR has a partially agnoistic effect. The aim of the present study was to demonstrate whether AVP-levels can be influenced during SAR-induced renin stimulation. In 9 patients with essential hypertension blood pressure dropped significantly under SAR (10 microgram/kg/min over a 30 min period). Before and after SAR plasma renin activity (PRA) and AVP were measured by RIA, SAR evoked significantly increments of PRA in all patients and of AVP in 6 patients. The increased serum concentrations of AVP following SAR may be explained either by the depressor effect of SAR, its diminished concentration at the central receptor, or a partial AII-agonistic effect.
已有研究描述了血管紧张素II(AII)对精氨酸加压素(AVP)分泌的中枢刺激作用。AII的竞争性阻断剂沙拉新(SAR)已被用于血管紧张素依赖性高血压的诊断。此外,SAR具有部分激动作用。本研究的目的是证明在SAR诱导肾素刺激期间,AVP水平是否会受到影响。9例原发性高血压患者在使用SAR期间(30分钟内以10微克/千克/分钟的速度给药)血压显著下降。在使用SAR前后,通过放射免疫分析法测定血浆肾素活性(PRA)和AVP,结果显示SAR使所有患者的PRA显著升高,6例患者的AVP显著升高。SAR给药后AVP血清浓度升高,这可能是由于SAR的降压作用、其在中枢受体处浓度降低,或部分AII激动作用所致。